Sildenafil in Heart Failure (SilHF); An Investigator Initiated Multinational Randomized Controlled Clinical Trial.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 24 Nov 2017
At a glance
- Drugs Sildenafil (Primary)
- Indications Chronic heart failure; Pulmonary hypertension
- Focus Therapeutic Use
- Acronyms SilHF
- 19 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 14 Aug 2017 Planned End Date changed from 1 Dec 2017 to 1 Jun2018.
- 14 Aug 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Mar 2018.